PRESS RELEASE published on 09/25/2023 at 07:06, 2 years 7 months ago Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)
PRESS RELEASE published on 09/19/2023 at 07:00, 2 years 7 months ago Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
PRESS RELEASE published on 09/14/2023 at 07:00, 2 years 7 months ago Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
PRESS RELEASE published on 09/11/2023 at 07:00, 2 years 7 months ago Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 09/04/2023 at 23:00, 2 years 8 months ago Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York
PRESS RELEASE published on 08/16/2023 at 07:00, 2 years 8 months ago Biophytis announces next regulatory steps in Europe and the United States for its COVA project
PRESS RELEASE published on 08/08/2023 at 07:00, 2 years 8 months ago Biophytis receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe
PRESS RELEASE published on 07/20/2023 at 07:00, 2 years 9 months ago Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19
PRESS RELEASE published on 07/19/2023 at 07:53, 2 years 9 months ago Biophytis Announces $3.8 Million Registered Direct Offering
PRESS RELEASE published on 07/18/2023 at 07:00, 2 years 9 months ago Biophytis and SEQENS sign a partnership to produce Sarconeos (BIO101) active compound
Published on 05/07/2026 at 02:00, 1 hour 31 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 4 hours 1 minute ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 4 hours 26 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 4 hours 31 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 5 hours 21 minutes ago Banyan Gold Announces Closing of $46.5 Million Private Placement
Published on 05/07/2026 at 00:47, 2 hours 44 minutes ago Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 2 hours 47 minutes ago EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 6 hours 59 minutes ago EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 7 hours 9 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 8 hours 13 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/06/2026 at 18:00, 9 hours 30 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 9 hours 31 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 17:45, 9 hours 46 minutes ago Information concerning the total number of voting rights and shares 2026 04 30
Published on 05/06/2026 at 17:45, 9 hours 46 minutes ago Declaration of voting rights at the end of April 2026
Published on 05/06/2026 at 17:45, 9 hours 46 minutes ago Accor - Information regarding availability and consultation of preparatory documents - Shareholders' Meeting of May 27, 2026
